Evidence map

GuidelineBritish journal of clinical pharmacology2026

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

Cinzia Dello Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 41338248